The Effects of Sevelamer Carbonate on Diabetic Nephropathy

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 117 participants.

Also called NCT01493050

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 117 participants (enrolled count) (from the registry)
Sponsor
Gary Striker (from the registry)
Registry
  • NCT NCT01493050
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01493050. Randomized; quadruple masking; primary purpose treatment. Start 2012-02 (registry gives no type); primary completion 2013-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effects of Sevelamer Carbonate on Diabetic Nephropathy
Condition
Diabetic Nephropathy
Intervention (Drug)
Sevelamer Carbonate
Intervention (Drug)
calcium carbonate
Lead sponsor
Gary Striker (class: other)

Record details

Record id
cardio:ct-nct01493050
Content hash
53d077808d5b4f8d3352e3b3cd51d1ea98d40304433193ecfd3bffabb6eef588